We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Guidance on medicines for food and non-food horses and record keeping requirements including the horse passport.
Plans to make better use of pharmacies, improve access to primary care and maximise the contribution of pharmacy professionals set out in new consultation.
Information on good laboratory, manufacturing and distribution practice, good pharmacovigilance practice (GPvP), out-of-specification investigations, inspection metrics and fees.
News and guidance on veterinary medicines issues affected by coronavirus (COVID-19).
Two pharmacists who sold ‘industrial’ quantities of Class C controlled drugs were yesterday sentenced to two years’ imprisonment each, suspended for 24 months, at Southwark Crown Court following an investigation by the Criminal Enforcement Unit of the Medicines and Healthcare...
Guidance for UK wholesalers and manufacturers on how to import human medicines including unlicensed medicines, how to apply for a licence and how much it costs.
Information about new applications, post-licensing, advertising, product information and fees.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
How to access the essential information you need when travelling to or living in Hong Kong as a British National.
Guidance for healthcare professionals on providing free prescriptions for participants in the HEAL-COVID or STIMULATE-ICP long COVID clinical trials.
Report of the review of the evidence for dependence on, and withdrawal from, prescribed medicines.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).